Juvenile Idiopathic Arthritis (JIA) is a group of chronic inflammatory joint conditions that begin in childhood. It is the most common form of arthritis in children and adolescents and may affect one joint or m…
Juvenile Idiopathic Arthritis (JIA) is a group of chronic inflammatory joint conditions that begin in childhood. It is the most common form of arthritis in children and adolescents and may affect one joint or multiple joints over time. Symptoms can range from mild joint swelling to more persistent inflammation that affects growth, mobility, and daily activities.
Early recognition and ongoing care are important, as untreated inflammation may interfere with joint development and overall well-being. With appropriate management, many children with JIA are able to remain active and participate fully in school, sports, and daily life.
Juvenile Idiopathic Arthritis is an autoimmune and inflammatory condition in which the immune system mistakenly targets the joints, leading to ongoing inflammation. The term “idiopathic” reflects that the exact cause is not always known.
JIA differs from adult forms of arthritis in how it presents and how it may affect growth and development. Some forms primarily affect a few joints, while others may involve many joints or have systemic features.
Symptoms of JIA can vary depending on the subtype but commonly include:
In some cases, symptoms may be subtle and noticed first as changes in activity level or coordination.
The exact cause of JIA is not fully understood, but contributing factors may include:
JIA is not caused by injury or overuse and is not contagious.
Diagnosis involves a comprehensive evaluation and may include:
Because symptoms may overlap with other pediatric conditions, careful assessment over time is often required.
Treatment plans are individualized and may evolve as a child grows. Management strategies often include:
The goal is to manage inflammation while supporting normal growth and development.
A pediatric or rheumatology evaluation may be appropriate if a child experiences:
Early evaluation may help guide appropriate care and monitoring.
Our approach focuses on comprehensive, family-centered care. We emphasize regular monitoring, individualized treatment planning, and close coordination to support both joint health and overall development.
For children who require advanced or infusion-based therapies, these treatments are provided in a carefully monitored and supportive environment. Our goal is to help children manage symptoms effectively while maintaining mobility, growth, and quality of life.
If your child is experiencing persistent joint symptoms or changes in mobility, scheduling a consultation can help clarify the diagnosis and discuss appropriate management options in a supportive clinical setting.